Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
Clinical Consultations™: Finding Opportunities to Improve the Management of Patients with Connective Tissue Disease-associated Pulmonary Arterial Hypertension (CTD-PAH)
Release Date: October 26, 2021
Expiration Date: October 26, 2022
Acknowledgement of Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate.
Upon successful completion of this activity, you should be better prepared to:
- Identify screening and diagnostic tests for patients at risk of CTD-PAH
- Evaluate clinical data for current and emerging therapeutic agents for the treatment of patients with CTD-PAH
- Develop individualized treatment plans to address the burden of CTD-PAH using shared decision-making
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities
Associate Professor of Medicine
Director, Stem Cell Transplant and Oncology ICU
Division of Pulmonary and Critical Care Medicine
Washington University School of Medicine
Disclosures: Colleen A. McEvoy, MD, has no relevant financial relationships with ineligible companies.
Department of Internal Medicine
St. Louis, MO
Disclosures: Colin E. Diffie, MD, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.